Research and Development at Quipolly
Quipolly Equine Centre is involved in two exciting areas of research and development in both equine reproduction and stem cell therapy for a range of conditions. Our two research partners are the University of Newcastle under the leadership of globally renowned fertility expert Professor John Aitken and Regeneus Pty Ltd - a Sydney based biotechnology company specialising in stem cell therapy for human and veterinary applications.
A summary of the projects to be undertaken with University of Newcastle are as follows;
- Examination and investigation of stallions with spontaneous sub-fertility and their diagnosis with advanced sperm analysis methods. This will include investigating semen extension, oxidative stress and cryopreservation.
- Examination and investigtion of stallions with normal fertility parallel to the above study.
- Field testing of semen extension strategies and media developed by University of Newcastle following on from the above two studies - insemination of test mares held at Quipolly with fresh, chilled and cryopreserved semen.
A summary of the projects to be undertaken with Regeneus Pty Ltd;
- The use of stem cell therapy to treat sub-fertility in mares.
- The use of stem cell therapy to treat musculoskeletal disorders such as degenerative joint disease, developmental disorders such as bone systs, tendon and ligament injuries, and laminitis (founder).
- The use of stem cell therapy to treat miscellaneous conditions such as corneal ulcers refractory to standard therapy, skin wounds etc.
Collaboration with these world-class partners, and a motivation to be involved in research and development, places Quipolly Equine Centre at the fore-front of equine veterinary science for the benefitt of Quipolly clients.